Evidence map›Paper›PMID 21252151›Full record

ReviewCirculation research2011

Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity.

Yury I Miller, Soo-Ho Choi, Philipp Wiesner, Longhou Fang, Richard Harkewicz, Karsten Hartvigsen, Agnès Boullier, Ayelet Gonen, Cody J Diehl, Xuchu Que and 5 more

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Circulation research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02428374 (Role of Innate and Adaptive Immunity After Acute Myocardial Infarction BATTLE-AMI Study), which is not on this map. Cited by 358 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
358citing papers in PubMed, 1 pooled it
23.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02428374 phase4unknown statusstarted 2015, after this paper: background citation

Role of Innate and Adaptive Immunity After Acute Myocardial Infarction BATTLE-AMI Study (B And T Types of Lymphocytes Evaluation in Acute Myocardial Infarction)

Ran2015Enrolled300Registered outcomes30Posted comparisons0ConditionsMyocardial FibrosisArmsRosuvastatin plus clopidogrel, Rosuvastatin plus ticagrelor, Simvastatin plus clopidogrel, Simvastatin plus ticagrelor
Open the trial in the graph
3 · Its place in the literature

Who cites it

358 citing papers in PubMed, 1 synthesis or guideline pooled it, 625 citations in OpenAlex.

  1. Pooled it
  2. Pretransplant natural antibody levels identify a subset of deceased donor kidney transplant recipients that benefit from infliximab induction.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2025
    Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Observational
  9. CD8Nature reviews. Cardiology · 2026
    Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Observational
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

298 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Yury I MillerDepartment of Medicine-MC0682, University of California-San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA. yumiller@ucsd.edu
Soo-Ho Choi
Philipp Wiesner
Longhou Fang
Richard Harkewicz
Karsten Hartvigsen
Agnès Boullier
Ayelet Gonen
Cody J Diehl
Xuchu Que
Erica Montano
Peter X Shaw
Sotirios Tsimikas
Christoph J Binder
Joseph L Witztum
Medical University of Vienna · ATAustrian Academy of Sciences · AT

Funding

STEROL LIPIDSU54GM069338 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DENNIS, EDWARD A · 2003 to 2013
$72.2M
Transcriptional GenomicsP01HL088093 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WITZTUM, JOSEPH L. · 2008 to 2018
$26.4M
Zebrafish models of vascular inflammation and atherosclerosisR01HL093767 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MILLER, YURY · 2009 to 2014
$2.5M
Early Forms of Oxidized LDL, TLRs and AtherosclerosisR01HL081862 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MILLER, YURY · 2006 to 2010
$2.1M
Development of a Vaccine Approach to Inhibit AtherosclerosisR01HL086559 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WITZTUM, JOSEPH L. · 2007 to 2011
$2.0M
NHLBI NIH HHS HL081862NHLBI NIH HHS HL086559NHLBI NIH HHS HL088093NHLBI NIH HHS HL093767NHLBI NIH HHS P01 HL088093NHLBI NIH HHS R01 HL081862NHLBI NIH HHS R01 HL086559NHLBI NIH HHS R01 HL093767NIGMS NIH HHS GM069338NIGMS NIH HHS U54 GM069338
6 · The paper itself

Abstract

Oxidation reactions are vital parts of metabolism and signal transduction. However, they also produce reactive oxygen species, which damage lipids, proteins and DNA, generating "oxidation-specific" epitopes. In this review, we discuss the hypothesis that such common oxidation-specific epitopes are a major target of innate immunity, recognized by a variety of "pattern recognition receptors" (PRRs). By analogy with microbial "pathogen-associated molecular patterns" (PAMPs), we postulate that host-derived, oxidation-specific epitopes can be considered to represent "danger (or damage)-associated molecular patterns" (DAMPs). We also argue that oxidation-specific epitopes present on apoptotic cells and their cellular debris provided the primary evolutionary pressure for the selection of such PRRs. Furthermore, because many PAMPs on microbes share molecular identity and/or mimicry with oxidation-specific epitopes, such PAMPs provide a strong secondary selecting pressure for the same set of oxidation-specific PRRs as well. Because lipid peroxidation is ubiquitous and a major component of the inflammatory state associated with atherosclerosis, the understanding that oxidation-specific epitopes are DAMPs, and thus the target of multiple arcs of innate immunity, provides novel insights into the pathogenesis of atherosclerosis. As examples, we show that both cellular and soluble PRRs, such as CD36, toll-like receptor-4, natural antibodies, and C-reactive protein recognize common oxidation-specific DAMPs, such as oxidized phospholipids and oxidized cholesteryl esters, and mediate a variety of immune responses, from expression of proinflammatory genes to excessive intracellular lipoprotein accumulation to atheroprotective humoral immunity. These insights may lead to improved understanding of inflammation and atherogenesis and suggest new approaches to diagnosis and therapy.

Indexed as

AnimalsAtherosclerosisEpitopesHumansImmunity, InnateOxidation-ReductionOxidative PhosphorylationReceptors, Pattern RecognitionEpitopesReceptors, Pattern Recognition

Identifiers

PMID21252151
PMCPMC3075542
OpenAlexW2134685432

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.